Home LiteratureArticle Details
PMID: 2567934 Published · ppublish English Comment Letter

In-vivo anti-CD3 treatment of autoimmune patients.

Lancet (London, England) ·Vol. 2 ·No. 8655 ·1989-07-15 ·Pages 164

Chatenoud L, Ferran C, Bach JF

Abstract

暂无摘要

MeSH Terms
Antibodies, Monoclonal/therapeutic use Antigens, Differentiation, T-Lymphocyte/immunology Autoimmune Diseases/therapy Diabetes Mellitus, Type 1/therapy Humans
Chemicals
Antibodies, Monoclonal Antigens, Differentiation, T-Lymphocyte
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Chatenoud L
Ferran C
Bach J F
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(89)90226-2
Published
1989-07-15
Pages
164
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentOn
PMID: 2567402
External Links
PubMed source DOI: 10.1016/s0140-6736(89)90226-2 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2